221 related articles for article (PubMed ID: 38279051)
1. Vascular injury activates the ELK1/SND1/SRF pathway to promote vascular smooth muscle cell proliferative phenotype and neointimal hyperplasia.
Su C; Liu M; Yao X; Hao W; Ma J; Ren Y; Gao X; Xin L; Ge L; Yu Y; Wei M; Yang J
Cell Mol Life Sci; 2024 Jan; 81(1):59. PubMed ID: 38279051
[TBL] [Abstract][Full Text] [Related]
2. Galangin inhibits neointima formation induced by vascular injury
Wu B; Xu C; Ding HS; Qiu L; Gao JX; Li M; Xiong Y; Xia H; Liu X
Food Funct; 2022 Nov; 13(23):12077-12092. PubMed ID: 36367287
[No Abstract] [Full Text] [Related]
3. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
[TBL] [Abstract][Full Text] [Related]
4. Semaphorin-3A protects against neointimal hyperplasia after vascular injury.
Wu JH; Zhou YF; Hong CD; Chen AQ; Luo Y; Mao L; Xia YP; He QW; Jin HJ; Huang M; Li YN; Hu B
EBioMedicine; 2019 Jan; 39():95-108. PubMed ID: 30579864
[TBL] [Abstract][Full Text] [Related]
5. Cell-Specific Effects of GATA (GATA Zinc Finger Transcription Factor Family)-6 in Vascular Smooth Muscle and Endothelial Cells on Vascular Injury Neointimal Formation.
Zhuang T; Liu J; Chen X; Pi J; Kuang Y; Wang Y; Tomlinson B; Chan P; Zhang Q; Li Y; Yu Z; Zheng X; Reilly M; Morrisey E; Zhang L; Liu Z; Zhang Y
Arterioscler Thromb Vasc Biol; 2019 May; 39(5):888-901. PubMed ID: 30943773
[TBL] [Abstract][Full Text] [Related]
6. Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation.
Wu W; Zhang W; Choi M; Zhao J; Gao P; Xue M; Singer HA; Jourd'heuil D; Long X
Redox Biol; 2019 Apr; 22():101137. PubMed ID: 30771750
[TBL] [Abstract][Full Text] [Related]
7. Hsa_circ_0001402 alleviates vascular neointimal hyperplasia through a miR-183-5p-dependent regulation of vascular smooth muscle cell proliferation, migration, and autophagy.
Lin JJ; Chen R; Yang LY; Gong M; Du MY; Mu SQ; Jiang ZA; Li HH; Yang Y; Wang XH; Wang SF; Liu KX; Cao SH; Wang ZY; Zhao AQ; Yang SY; Li C; Sun SG
J Adv Res; 2024 Jun; 60():93-110. PubMed ID: 37499939
[TBL] [Abstract][Full Text] [Related]
8. Novel role of copper transport protein antioxidant-1 in neointimal formation after vascular injury.
Kohno T; Urao N; Ashino T; Sudhahar V; McKinney RD; Hamakubo T; Iwanari H; Ushio-Fukai M; Fukai T
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):805-13. PubMed ID: 23349186
[TBL] [Abstract][Full Text] [Related]
9. Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia.
Ashino T; Yamamoto M; Yoshida T; Numazawa S
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):760-8. PubMed ID: 23413426
[TBL] [Abstract][Full Text] [Related]
10. Plin5 inhibits proliferation and migration of vascular smooth muscle cell through interacting with PGC-1α following vascular injury.
Gan X; Zhao J; Chen Y; Li Y; Xuan B; Gu M; Feng F; Yang Y; Yang D; Sun X
Bioengineered; 2022 Apr; 13(4):10665-10678. PubMed ID: 35470759
[TBL] [Abstract][Full Text] [Related]
11. G6PD maintains the VSMC synthetic phenotype and accelerates vascular neointimal hyperplasia by inhibiting the VDAC1-Bax-mediated mitochondrial apoptosis pathway.
Zhang T; Cao RJ; Niu JL; Chen ZH; Mu SQ; Cao T; Pang JX; Dong LH
Cell Mol Biol Lett; 2024 Apr; 29(1):47. PubMed ID: 38589823
[TBL] [Abstract][Full Text] [Related]
12. Suv39h1 downregulation inhibits neointimal hyperplasia after vascular injury.
Zhang J; Chen J; Yang J; Xu C; Hu Q; Wu H; Cai W; Guo Q; Gao W; He C; Yang C; Yang J
Atherosclerosis; 2019 Sep; 288():76-84. PubMed ID: 31330382
[TBL] [Abstract][Full Text] [Related]
13. Glycolysis and de novo fatty acid synthesis cooperatively regulate pathological vascular smooth muscle cell phenotypic switching and neointimal hyperplasia.
Cao K; Zhang T; Li Z; Song M; Li A; Yan J; Guo S; Wang L; Huang S; Li Z; Hou W; Dai X; Wang Y; Feng D; He J; Fu X; Xu Y
J Pathol; 2023 Apr; 259(4):388-401. PubMed ID: 36640260
[TBL] [Abstract][Full Text] [Related]
14. Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs.
He YH; Wang XQ; Zhang J; Liu ZH; Pan WQ; Shen Y; Zhu ZB; Wang LJ; Yan XX; Yang K; Zhang RY; Shen WF; Ding FH; Lu L
Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):717-729. PubMed ID: 28183701
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial Protein Poldip2 (Polymerase Delta Interacting Protein 2) Controls Vascular Smooth Muscle Differentiated Phenotype by O-Linked GlcNAc (N-Acetylglucosamine) Transferase-Dependent Inhibition of a Ubiquitin Proteasome System.
Paredes F; Williams HC; Quintana RA; San Martin A
Circ Res; 2020 Jan; 126(1):41-56. PubMed ID: 31656131
[TBL] [Abstract][Full Text] [Related]
16. Role of PCK2 in the proliferation of vascular smooth muscle cells in neointimal hyperplasia.
Ko DS; Kang J; Heo HJ; Kim EK; Kim K; Kang JM; Jung Y; Baek SE; Kim YH
Int J Biol Sci; 2022; 18(13):5154-5167. PubMed ID: 35982907
[TBL] [Abstract][Full Text] [Related]
17. IQGAP1 links PDGF receptor-β signal to focal adhesions involved in vascular smooth muscle cell migration: role in neointimal formation after vascular injury.
Kohno T; Urao N; Ashino T; Sudhahar V; Inomata H; Yamaoka-Tojo M; McKinney RD; Fukai T; Ushio-Fukai M
Am J Physiol Cell Physiol; 2013 Sep; 305(6):C591-600. PubMed ID: 23657573
[TBL] [Abstract][Full Text] [Related]
18. NF2 deficiency accelerates neointima hyperplasia following vascular injury via promoting YAP-TEAD1 interaction in vascular smooth muscle cells.
Sun X; Li S; Gan X; Chen K; Yang D; Yang Y
Aging (Albany NY); 2020 May; 12(10):9726-9744. PubMed ID: 32422606
[TBL] [Abstract][Full Text] [Related]
19. The downstream network of STAT6 in promoting vascular smooth muscle cell phenotypic switch and neointimal formation.
Ding S; Wang X; Wang Y; Zhang Z; Yang X; Zhu X; Zhu B; Xiao C; Ge J; Yang X
Cell Biol Int; 2023 Sep; 47(9):1573-1588. PubMed ID: 37303238
[TBL] [Abstract][Full Text] [Related]
20. PPARγ modulates vascular smooth muscle cell phenotype via a protein kinase G-dependent pathway and reduces neointimal hyperplasia after vascular injury.
Yang HM; Kim BK; Kim JY; Kwon YW; Jin S; Lee JE; Cho HJ; Lee HY; Kang HJ; Oh BH; Park YB; Kim HS
Exp Mol Med; 2013 Nov; 45(11):e65. PubMed ID: 24287871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
